ArticleThe oncologist2019

Monitoring Serum VEGF in Neoadjuvant Chemotherapy for Patients with Triple-Negative Breast Cancer: A New Strategy for Early Prediction of Treatment Response and Patient Survival.

Ruo-Xi Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.